Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Completed · Phase 2

Conditions studied: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes

In brief

RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy and radiation therapy used to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients who have hematologic cancer.

Key facts

Study ID

NCT00005854

Run by

Fred Hutchinson Cancer Center

Starts

1999-12-01

Expected to finish

2000-10-01

Last updated by the study team

2011-11-30

Who can join

Age: any, up to 50. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
• University of South Carolina School of Medicine — Columbia, South Carolina, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.